Sun Pharma to acquire 11.28 pc stake in Zenotech from Daiichi Sankyo
PTI, Mar 22, 2022, 9:14 AM IST
Image credit: Reuters
New Delhi: Sun Pharmaceutical Industries on Monday said it has entered into a share purchase agreement with Japan’s Daiichi Sankyo Company to acquire the latter’s 11.28 percent stake in Zenotech Laboratories.
Sun Pharma said it will pay Rs 5.32 crore for the stake.
The primary objective of the transaction from the acquirer’s perspective is to consolidate its holding in the target company, the Mumbai-based drug firm said in a regulatory filing.
After the acquisition, Sun Pharma’s stake in Zenotech will increase from 57.56 percent to 68.84 percent, it added.
The acquisition is expected to complete in 30 days.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Markets rebound in early trade after sharp decline in previous session
Reliance Consumer Products enters rehydration category
Table Space Founder Amit Banerji died
Prices of tomato, potato in bitter taste; home-cooked meals get costlier in Dec: Report
Govt considering mandatory hallmarking for silver after consumer demands
MUST WATCH
Latest Additions
Nine RSS workers sentenced to life for 2005 murder of CPI(M) worker in Kerala
China shuts down Mt Everest scenic area after 6.8-magnitude quake hits Tibet
Indo-Pak war veteran Havaldar Baldev Singh passes away in Rajouri at 93
Shah launches ‘Bharatpol’ for international police assistance, asks agencies to use modern tech
Wamiqa Gabbi joins Adivi Sesh in ‘Goodachari 2’
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.